CClinicalTrials.gg
RecruitingNCT06818942Updated May 7, 2026

Nomogram for Predicting Difficult Laparoscopic Appendectomy

An observational study in Emergencies, sponsored by Shanghai 6th People's Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Shanghai 6th People's Hospital · Observational

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Sex
All
01

Study summary

No prior studies have stratified the difficulty of laparoscopic appendectomy (LA). The investigators aimed to investigate preoperative factors as indicators of difficult LAs based on the experience of surgical trainees and to develop a predictive model accordingly.

Read the detailed description

Acute appendicitis is the most common cause of surgical emergencies and laparoscopic appendectomy (LA) is usually attempted by surgical trainees. This study aim to explore the preoperative and intraoperative factors affecting the degree of surgical difficulty and to establish a model for validation, so that it can be subsequently replicated in training programs.

02

Conditions studied

  • Emergencies

Browse trials for

Keywords

  • Laparoscopic appendectomy
  • Surgical difficulty
  • Training program
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's planned enrollment of 500 is above the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Shanghai 6th People's Hospital is the lead sponsor of 69 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with confirmed acute appendicitis, were willing to and suitable to undergo laparoscopic appendectomy (LA). Patients were well informed about the surgical procedure and were aware of the potential benefits and risks. Patient consented for us to use perioperative data.

Inclusion criteria

  • Clinical diagnosis of acute appendicitis
  • Participants who underwent laparoscopic appendectomy

Exclusion criteria

Exclusion Criteria:

  • Participants refused or could not tolerate laparoscopic appendectomy
  • Incomplete preoperative examination or missed information
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • Difficult laparoscopic appendectomy

    (1) operative time more than 75% of the overall study cases (2) severe intraoperative vascular or uncontrolled bleeding (3) conversion to open approach

    Other: Observations on preoperative and intraoperative factors influencing the difficulty of surgery

  • Non-difficult laparoscopic appendectomy

    the remaining of the entire study cases excluding the difficult cases

    Other: Observations on preoperative and intraoperative factors influencing the difficulty of surgery

Interventions

  • OtherObservations on preoperative and intraoperative factors influencing the difficulty of surgery

    Age, body mass index, gender, inflammatory indicators, previous history of abdominal surgery, underlying disease

06

What researchers measure

Primary outcomes

  1. Operative time

    operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet

    Time frame: During surgery

  2. Number of participants with postoperative complications

    Postoperative bleeding, surgical site infection and other complications

    Time frame: through study completion, an average of 1 year

  3. Hospitalization

    days of hospitalization

    Time frame: 1 day of discharge

  4. Degree of pain

    pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain

    Time frame: approximately 4 hours after surgery and on postoperative day 1

07

Study locations

1 of 1 sites recruiting
  • Shanghai Sixth People's Hospital
    Shanghai, Shanghai Municipality 200233, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data are available on request due to privacy or other restrictions. The data that support the findings of this study are available on request from Ling Zhan. The data are not publicly available due to them containing information that could compromise research participant privacy.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06818942
Lead sponsor
Shanghai 6th People's Hospital
Responsible party
Ling Zhan (Principal Investigator, Shanghai 6th People's Hospital) — Principal investigator
First posted
Feb 11, 2025
Start date
Jan 26, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
May 7, 2026

Study contacts

Ling Zhan, Dr
Contact
rebecca0428zhan@163.com
08615821120972

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion